BSE See NSE See 47,705.80
-243.62 (-0.51%)
Another Opportunity in the Wings

Another Opportunity in the Wings


I cannot help but share my excitement with you, dear readers and investors, about this special anniversary issue that celebrates Dalal Street Investment Journal’s landmark completion of 35 years. Today, DSIJ has grown sharper, smarter and a better forecaster of market trends.  

To read the entire article, you must be a DSIJ magazine subscriber.



Comments are only visible to subscribers.

DSIJ Mindshare

Caplin Point subsidiary gets USFDA approval for Milrinone Lactate injection

Ganesh V / Article rating: 4.5

Caplin Point Laboratories Limited announced on Monday after the market hours that its subsidiary company, Caplin Steriles Limited, has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Milrinone Lactate injection.